- Foreword
- Advisory Board
- Introduction - CCT
- Training and Education
Provided by CCT
- SFDA Inspection and Accreditation
- Ethics Committee
- Central Laboratories
- Clinical Trials Capabilities
 Cardiology
 Clinical Oncology
 Digestive and
 Liver Diseases
 Endocrinology
   Ophthalmology
   Phase I Studies Unit
   Paediatrics
   Anaesthesia and
 Intensive Care
   Community and
 Family Medicine
   Neurology
   Orthopedic and
 Traumatology
   Psychiatry
   Rheumatology
   Surgery
 
 

Clinical Trials Capabilities > Anaesthesia and Intensive Care

Strength and Expertise

The Department has expertise in:

  • Conducting Phase II-IV clinical trials in anesthesia (including obstetric, trauma, regional, cardiothoracic, neurosurgical, and pediatric), perioperative (including traditional Chinese medicine and acupuncture), pain and intensive care medicine;
  • Performing invasive and noninvasive hemodynamic and coagulation monitoring;
  • Performing neurophysiologic and cerebral function monitoring;
  • Carrying out advanced neuropsychology tests;
  • Using advanced real-time ultrasound techniques for regional anesthesia;
  • Conducting quality of life research for perioperative, pain and intensive care medicine;
  • Performing complex pharmacokinetic modeling (NONMEM, Kinetica);
  • Systematic analysis (by Cochrane editor)
  • Epidemiological studies

The department has participated in planning and endpoint adjudication for major international trials.

Special Facility and Equipment

  • Dedicated laboratory with HPLC MS/MS for analysis of drug assays (including antibiotics, antiviral agents, intravenous anesthetics, opioids, antiemetics, etc.)
  • Dedicated IT officers for developing web based CRF, data entry.

Collaboration, Partners and Multi-centre Trials Capability

  • Overseas collaborations:
    • China: Peking Union Medical Center
    • Europe: Institute of Clinical Research, Odense University, Denmark, European Society of Intensive Care Medicine, University of Birmingham
    • Australia: Australian and New Zealand College of Anaesthetists (ANZCA) Trial group, Australian and New Zealand Intensive Care Society Clinical Trials Group, University of Queensland
    • US: University of California, San Francisco
    • Canada: McMaster University, Hamilton; University of Western Ontario, London Ontanrio
    • Singapore: Intensive Care Units, Tan Tock Seng Hospital
    • Saudi Arabia: King Saud Bin Abdulaziz University for Health Sciences, Riyadh
  • Industrial collaboration:
    • Glaxo-Smith-Kline
    • Novartis
    • Pfizer
    • Progenics
    • Nova Nordisk
    • Eisai

 

  • Collaborators in local institutions:
    • United Christian Hospital
    • Tuen Mum Hospital
    • North District Hospital
    • Alice Ho Miu Ling Nethersole Hospital
    • Kwong Wah Hospital

Clinical Trials Monitored and/or Audited by Industry, FDA and local RGC etc.

  • Glaxo-Smith-Kline on antiemetic drug trials (September, 2006)
  • Canadian Cardiovascular Collaboration, HGH-McMaster Clinic, Population Health Research Institute, McMaster University, Canada (April, 2007)
  • Treatment of Candidaemia (Pfizer)
  • Treatment of MRSA pneumonia (Pfizer)
  • Sepsis treatment (Eisai)